Keywords: schering-plough, settles, claritin-d, patent, litigation, impax, reached
Schering-Plough settles Claritin-D patent litigation with Impax
Article | 03 November 2003
Schering-Plough has reached a settlement with Impax Laboratoriesresolving litigation related to the latter's generic version of S-P's Claritin D (loratadine) 24 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
